The absolute number of DVT events across all 21 trials was small, which is exactly why the confidence interval stretches so wide, from 1.09 to 12.25
Technically, when the FDA first yanked tirzepatide off its shortage list in October 2024, both 503As and 503Bs could no longer legally make copycats (with one notable exception for the smaller 503As, who could still fill individual prescriptions if there was a medical reason the patient needed a slightly different version than the brand-name drugmore on this later)
Tirzepatide (Zepbound): Showed up to 20.9% average weight reduction at the highest dose in the SURMOUNT-1 trial
Most DOZA clients note that already in the first month, appetite decreases significantly, and the feeling of satiety after eating becomes natural
Louis location, focusing on steady, long-term success